LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 99 of 166
Next
>>
>
2451 to 2475 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	JNK-9L	0.37	uM	LJP6	72	hr	1334	3591	3925	0.9150	0.8889
BT-20	JNK-9L	1.11	uM	LJP6	72	hr	1334	2899	3925	0.7385	0.6453
BT-20	JNK-9L	3.33	uM	LJP6	72	hr	1334	1845	3925	0.4700	0.2313
BT-20	JNK-9L	10	uM	LJP6	72	hr	1334	704	3925	0.1794	-0.3370
BT-20	PD0325901	0.04	uM	LJP5	72	hr	1334	3887	4033	0.9640	0.9546
BT-20	PD0325901	0.04	uM	LJP6	72	hr	1334	3800	3925	0.9687	0.9587
BT-20	PD0325901	0.12	uM	LJP5	72	hr	1334	3846	4033	0.9540	0.9421
BT-20	PD0325901	0.12	uM	LJP6	72	hr	1334	3518	3925	0.8972	0.8592
BT-20	PD0325901	0.37	uM	LJP5	72	hr	1334	3752	4033	0.9305	0.9111
BT-20	PD0325901	0.37	uM	LJP6	72	hr	1334	3522	3925	0.8978	0.8637
BT-20	PD0325901	1.11	uM	LJP5	72	hr	1334	3477	4033	0.8622	0.8223
BT-20	PD0325901	1.11	uM	LJP6	72	hr	1334	3222	3925	0.8213	0.7610
BT-20	PD0325901	3.33	uM	LJP5	72	hr	1334	3046	4033	0.7547	0.6750
BT-20	PD0325901	3.33	uM	LJP6	72	hr	1334	2453	3925	0.6256	0.4726
BT-20	PD0325901	10	uM	LJP5	72	hr	1334	2557	4033	0.6336	0.5011
BT-20	PD0325901	10	uM	LJP6	72	hr	1334	2322	3925	0.5926	0.4174
BT-20	Geldanamycin	0.04	uM	LJP5	72	hr	1334	1781	4033	0.4425	0.1988
BT-20	Geldanamycin	0.04	uM	LJP6	72	hr	1334	2191	3925	0.5589	0.3709
BT-20	Geldanamycin	0.12	uM	LJP5	72	hr	1334	1117	4033	0.2772	-0.1054
BT-20	Geldanamycin	0.12	uM	LJP6	72	hr	1334	1210	3925	0.3086	-0.0613
BT-20	Geldanamycin	0.37	uM	LJP5	72	hr	1334	1009	4033	0.2505	-0.1606
BT-20	Geldanamycin	0.37	uM	LJP6	72	hr	1334	991	3925	0.2525	-0.1743
BT-20	Geldanamycin	1.11	uM	LJP5	72	hr	1334	976	4033	0.2421	-0.1782
BT-20	Geldanamycin	1.11	uM	LJP6	72	hr	1334	968	3925	0.2467	-0.1864
BT-20	Geldanamycin	3.33	uM	LJP5	72	hr	1334	870	4033	0.2160	-0.2349

|<
<<
Previous
Page 99 of 166
Next
>>
>
2451 to 2475 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)